cato.com
Cato. Partner with the experts at CATO SMS for your complex therapeutics and regulatory services solutions..
Allucent: CRO Bringing Innovation to Biopharma Companies
Cato.com has yet to be estimated by Alexa in terms of traffic and rank. Moreover, Cato has yet to grow their social media reach, as it’s relatively low at the moment: 61 StumbleUpon views and 34 Google+ votes. This site’s reputation is almost good, but it is important to note that its child safety remains unrated by users.
Popular pages to visit on cato.com
Home - Allucent
Welcome to ourjourney in drug development Watch Full Video Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines Read More Congratulations Dr. Goldberg o...
Domain info
| Location: | United States |
| Owned by: | On behalf of cato.com owner (Identity Protection Service) |
| Hosted by: | Amazon Technologies Inc. |
| Registered by: | Amazon Registrar, Inc. |
| Subnetworks: | 52.216.51.101, 52.216.104.98, 52.216.207.2, 52.217.42.179, 52.217.134.245, 52.217.198.69, 52.217.229.93, 54.231.226.141 |
More domains registered by Amazon Registrar, Inc.
Social Networks Activity
| Facebook likes: | - |
| Twitter mentions: | - |
| Google pluses: | 34 |
| LinkedIn mentions: | - |
| Pinterest pins: | - |
| StumbleUpon views: | 61 |
